Beasley Allen is honored to represent a Montgomery County, Alabama resident who developed non-Hodgkin’s lymphoma as a result of years of Roundup exposure, both commercially throughout his career and in personal home use. The lawsuit is against Monsanto, which has faced consecutive Plaintiff verdicts in the first three national trials. This case, being handled by John Tomlinson and Rhon Jones, is set for trial in October 2020.
This is Beasley Allen’s second Roundup trial set for 2020. As previously reported, the first trial will take place in Dallas County in March. In that case, Beasley Allen is representing a local Plaintiff whose non-Hodgkin’s lymphoma is linked to years of Roundup exposure.
For nearly 40 years, farmers across the world have used Roundup without knowledge of the dangers posed by its use. Monsanto, the maker of the popular weed killer, has failed to place a warning label on its product informing the consumer that the product contains carcinogenic properties, in particular the chemical glyphosate. In 2015, the World Health Organization found that glyphosate, the principal “weedkiller” component of Roundup, was carcinogenic to humans and could lead to the development of non-Hodgkin’s lymphoma. Monsanto has continued to assure the public that the product is harmless and poses no danger to its users. The company is currently facing more than 10,000 similar lawsuits.
German-based Bayer AG paid $63 billion to acquire chemical company Monsanto in June 2018.
Beasley Allen lawyers are currently representing hundreds of clients who have been exposed to Roundup and developed non-Hodgkin’s lymphoma. We would welcome the opportunity to speak with you regarding these cases.
This story appears in the September 2019 issue of The Jere Beasley Report. For more like this, visit the Report online and subscribe.
